| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 20.497 | 40.442 | 58.816 | 63.979 | 64.230 | 69.822 | 98.536 | 144.045 |
| Total Income - EUR | - | - | 20.498 | 40.442 | 58.817 | 65.013 | 65.242 | 69.822 | 98.536 | 158.568 |
| Total Expenses - EUR | - | - | 13.394 | 30.186 | 31.434 | 48.882 | 54.823 | 63.634 | 82.160 | 97.438 |
| Gross Profit/Loss - EUR | - | - | 7.104 | 10.256 | 27.383 | 16.132 | 10.419 | 6.189 | 16.376 | 61.130 |
| Net Profit/Loss - EUR | - | - | 6.899 | 9.852 | 26.795 | 15.737 | 9.767 | 5.490 | 15.581 | 56.528 |
| Employees | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 |
Check the financial reports for the company - Medisiad Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 25.937 | 17.789 | 39.096 | 35.154 | 58.565 |
| Current Assets | - | - | 9.262 | 18.850 | 46.699 | 53.842 | 65.992 | 21.265 | 36.618 | 84.421 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.347 | 3.538 | 4.754 | 11.589 | 7.093 | 5.604 | 22.332 | 26.428 |
| Cash | - | - | 6.915 | 15.313 | 41.945 | 42.253 | 58.900 | 15.661 | 14.286 | 57.992 |
| Shareholders Funds | - | - | 6.943 | 16.667 | 43.139 | 58.059 | 66.538 | 21.541 | 38.670 | 56.576 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.319 | 2.183 | 3.560 | 21.721 | 17.244 | 38.820 | 33.101 | 86.410 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medisiad Srl